Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)
Clinical trial NCT00086671 · COMPLETED
Trial details
- NCT number
- NCT00086671
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2006-11-01
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.